Pharmacokinetics and Pharmacodynamics of Intravenous Levofloxacin in Patients with Early-Onset Ventilator-Associated Pneumonia
Authors:
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (6) , 589-598
Abstract
To investigate the pharmacokinetics of levofloxacin and the pharmacokinetic-pharmacodynamic appropriateness of its total body exposure in patients in the intensive care unit (ICU) treated for early-onset ventilator-associated pneumonia (VAP) with intravenous levofloxacin 500mg twice daily. Prospective non-blinded pharmacokinetic-pharmacodynamic study. Ten critically ill adult patients with normal renal function. Blood and urine samples were collected at appropriate times during a 12-hour administration interval at steady state. Levofloxacin concentrations were determined by high-performance liquid chromatography. Clinical and microbiological outcomes were assessed. Levofloxacin pharmacokinetics were only partially comparable with those obtained from literature data for healthy volunteers. Area under the concentration-time curve (AUCτ) over the 12-hour dosage interval was about 30–40)% lower than in healthy volunteers (33.90 vs 49.60 mg · h/L). The reduced exposure may be due to a greater clearance of levofloxacin (0.204 vs 0.145 L/h/kg [3.40 vs 2.42 mL/min/kg]), leading to a shorter elimination half-life (5.2 vs 7.6 hours). Cumulative urinary excretion during the 12-hour dosage interval confirmed the greater excretion of unchanged drug in these patients compared with healthy subjects (76% vs 68%). Coadministered drugs used to treat underlying diseases (dopamine, furosemide, mannitol) may at least partially account for this enhanced elimination in critically ill patients. Intravenous levofloxacin 500mg twice daily ensured a median Cmax/MIC (maximum plasma concentration/minimum inhibitory concentration) ratio of 102 and a median 24-hour AUC/MIC ratio of 930 SIT−1 · h (inverse serum inhibitory titre integrated over time) against methicillinsensitive Staphylococcus aureus and Haemophilus influenzile. The overall success rate of the assessable cases was 75% (6/8). Bacterial eradication was obtained in all of the assessable cases (8/8), but a superinfection (Acinetobacter anitratus, Pseudomonas aeruginosa) occurred in three cases. The findings support the suitability of intravenous levofloxacin 500mg twice daily in the treatment of early-onset VAP in ICU patients with normal renal function. Levofloxacin may represent a valid alternative to non-pseudomonal β-lactams or aminoglycosides in the empirical treatment of early-onset VAP. However, further larger studies are warranted to investigate its efficacy.Keywords
This publication has 34 references indexed in Scilit:
- Activities of Trovafloxacin, Gatifloxacin, Clinafloxacin, Sparfloxacin, Levofloxacin, and Ciprofloxacin against Penicillin-Resistant Streptococcus pneumoniae in an In Vitro Infection ModelAntimicrobial Agents and Chemotherapy, 2000
- Pharmacodynamics of Trovafloxacin, Ofloxacin, and Ciprofloxacin against Streptococcus pneumoniae in an In Vitro Pharmacokinetic ModelAntimicrobial Agents and Chemotherapy, 1999
- Renal effects of low-dose dopamine during vasopressor therapy for posttraumatic intracranial hypertension.Intensive Care Medicine, 1999
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniaeJournal of Antimicrobial Chemotherapy, 1999
- Pharmacokinetics and Pharmacodynamics of FluoroquinolonesDrugs, 1999
- Double-Blind Evaluation of the Safety and Pharmacokinetics of Multiple Oral Once-Daily 750-Milligram and 1-Gram Doses of Levofloxacin in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 1998
- Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous dosesAntimicrobial Agents and Chemotherapy, 1997
- A Prospective, Randomized Comparison of an In-Line Heat Moisture Exchange Filter and Heated Wire HumidifiersChest, 1997
- Pharmacodynamics of intravenous ciprofloxacin in seriously ill patientsAntimicrobial Agents and Chemotherapy, 1993
- Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistanceAntimicrobial Agents and Chemotherapy, 1987